West africa charts new path in local drug production in Lomé summit

Lomé, August 13, 2026 — West Africa stands at a critical juncture where the region must choose between massive drug imports or building its own health industry. This stark reality brought together medical and academic leaders across the subregion on August 12 at the Agora Senghor in Lomé, laying the groundwork for a complete overhaul of West African health strategies.

The 21st edition of the West African Pharmaceutical Students Federation (FESPAO) Scientific and Cultural Conference revealed a new generation of medical professionals no longer content with mere budget requests. They are demanding a fundamental shift in doctrine: moving away from a distribution-only model to embrace industrialization, genomic research, and the scientific validation of traditional knowledge.

Local manufacturing: a national security imperative

The global pandemic and recent logistical crises served as wake-up calls for the continent. Relying on pharmaceutical imports is no longer just an economic oddity—it poses a major national security vulnerability. This was the central argument presented during the summit.

The Togolese government, led by Professor Gado Tchangbédji, Minister Delegate for Higher Education and Research, and backed by President Faure Essozimna Gnassingbé, has set a bold new course. Innovation and local pharmaceutical production will serve as the subregion’s shields against future pandemics. To achieve this, the state is committing to strong support for scientific cooperation and applied research.

The genomic epidemiology and indigenous knowledge wager

Local production alone is insufficient if it merely replicates foreign patents. True sovereignty requires treatments tailored to the continent’s specific needs. By placing genomic epidemiology at the heart of discussions, the Lomé Conference highlights an urgent scientific need: developing therapies calibrated to Africa’s genetic heritage, which has been largely overlooked in global clinical trials.

This cutting-edge science is complemented by a bold cultural reappropriation. Experts advocate for the industrial valorization of traditional pharmacopeia. No longer should herbal medicine remain informal; instead, it must undergo rigorous clinical trials to patent new, 100% African active molecules.

Redefining the pharmacist’s role

This industrial and scientific ambition faces a human capital challenge. As the sector evolves, academic training must keep pace. Professor Tchin Darré, Minister Delegate for Health and Dean of the Faculty of Health Sciences at the University of Lomé, pinpointed the key to this revolution: curriculum reform. Tomorrow’s West African pharmacist cannot remain confined to dispensing medication behind a counter. They must become a cutting-edge researcher, a key player in manufacturing, and an expert in validating indigenous knowledge.

As discussions continue in Lomé, the 21st Conference’s goal is clear: transform these academic debates into binding public policy proposals. The aim is to ensure universal healthcare access in West Africa is no longer hostage to factories located thousands of kilometers away from patients.

In essence, the stakes are vital. Without a robust local pharmaceutical industry and research rooted in African realities, West Africa will remain dependent on solutions from elsewhere. In the face of future pandemics, this dependence could cost lives. True health sovereignty will be determined by states’ ability to turn these resolutions into concrete actions, ensuring every African patient has access to care designed, validated, and produced on their own continent.